Retinoblastoma clinical trials
14 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Retinoblastoma Phase II Expanded Access Clinical Trial
- A Study to Give Treatment Inside the Eye to Treat Retinoblastoma
- Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.
- Retinoblastoma Patient Clinical Database and Tissue Repository
- Studying Health Outcomes After Treatment in Patients With Retinoblastoma
- Determining Whether Multiple Anesthesia Exposures Affect Cognitive Function for Retinoblastoma Patients
- A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)
- End Diagnostic Overshadowing:Addressing Ableism in Diagnoses
- Familial Investigations of Childhood Cancer Predisposition
- Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
- Molecular Analysis Of Solid Tumors
- GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma
- Effect of Treatment Modality on Psychosocial Functioning of Survivors of Unilateral Retinoblastoma
- Early Check: Expanded Screening in Newborns
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Retinoblastoma” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.